Engineers Gate Manager LP Purchases 120,006 Shares of HealthEquity, Inc. $HQY

Engineers Gate Manager LP boosted its position in HealthEquity, Inc. (NASDAQ:HQY) by 161.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 194,392 shares of the company’s stock after acquiring an additional 120,006 shares during the period. Engineers Gate Manager LP’s holdings in HealthEquity were worth $17,808,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. William Blair Investment Management LLC bought a new position in shares of HealthEquity in the fourth quarter valued at approximately $169,956,000. Norges Bank bought a new position in shares of HealthEquity in the fourth quarter valued at approximately $66,927,000. AQR Capital Management LLC lifted its holdings in shares of HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after purchasing an additional 661,795 shares in the last quarter. Cadian Capital Management LP bought a new position in shares of HealthEquity in the fourth quarter valued at approximately $51,915,000. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in shares of HealthEquity by 229,985.6% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 478,578 shares of the company’s stock valued at $43,843,000 after purchasing an additional 478,370 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

Shares of HQY opened at $86.33 on Thursday. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $7.22 billion, a price-to-earnings ratio of 32.33, a PEG ratio of 1.44 and a beta of 0.21. The stock has a 50 day moving average of $84.76 and a 200 day moving average of $85.35. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $106.60.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. The trade was a 11.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 13,081 shares of company stock valued at $1,193,000 over the last ninety days. 1.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. JPMorgan Chase & Co. dropped their target price on HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a report on Wednesday, March 18th. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a report on Thursday, March 19th. Royal Bank Of Canada raised their target price on HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a report on Wednesday, June 3rd. Finally, Wells Fargo & Company set a $111.00 target price on HealthEquity in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.